Non-toxic conjugates are compounds formed by linking a therapeutic agent to a carrier molecule that does not induce toxicity, allowing for targeted delivery of drugs while minimising side effects. This approach is significant in clinical practice as it enhances the efficacy of treatments, particularly in oncology, by directing drugs to cancer cells while sparing healthy tissue. A key example is antibody-drug conjugates, which combine monoclonal antibodies with cytotoxic agents to treat specific malignancies.

Please confirm you want to block this member.
You will no longer be able to:
Please allow a few minutes for this process to complete.